Quantitative single-cell functional characterization of CD19-specific chimeric antigen receptor T cells

被引：0
|
作者：
Varadarajan, Navin [1 ]
Liadi, Ivan [1 ]
Romain, Gabrielle [1 ]
Singh, Harjeet [2 ]
Cooper, Laurence [2 ]
机构：
[1] Univ Houston, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF IMMUNOLOGY | 2013年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P4344
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells
    T Numbenjapon
    L M Serrano
    H Singh
    C M Kowolik
    S Olivares
    N Gonzalez
    W C Chang
    S J Forman
    M C Jensen
    L J N Cooper
    Leukemia, 2006, 20 : 1889 - 1892
  • [22] Characterization of an artificial antigen-presenting cell to propagate CD19-specific cytolytic T cells
    Numbenjapon, T.
    Serrano, L. M.
    Singh, H.
    Kowolik, C. M.
    Olivares, S.
    Gonzalez, N.
    Chang, W. C.
    Forman, S. J.
    Jensen, M. C.
    Cooper, L. J. N.
    LEUKEMIA, 2006, 20 (10) : 1889 - 1892
  • [23] Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL
    Maude, Shannon L.
    Teachey, David T.
    Rheingold, Susan R.
    Shaw, Pamela A.
    Aplenc, Richard
    Barrett, David Maxwell
    Barker, Christine S.
    Callahan, Colleen
    Frey, Noelle V.
    Nazimuddin, Farzana
    Lacey, Simon F.
    Zheng, Zhaohui
    Levine, Bruce
    Melenhorst, Jan Joseph
    Motley, Laura
    Porter, David L.
    June, Carl H.
    Grupp, Stephan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Long-Term Remission of CLL Sustained by Oligoclonal CD19-Specific Chimeric Antigen Receptor T Cell Clones
    Melenhorst, J. Joseph
    Porter, David L.
    Nobles, Christopher L. L.
    Wang, Meng
    Tian, Lifeng
    Lacey, Simon F.
    Aliano, Cecile
    Fraietta, Joseph
    Frey, Noelle V.
    Kulikovskaya, Irina
    Gupta, Minnal
    Young, Regina M.
    Levine, Bruce L.
    Siegel, Donald L.
    Wherry, E. John
    Bushman, Frederic D.
    June, Carl H.
    MOLECULAR THERAPY, 2019, 27 (04) : 169 - 169
  • [25] Efficacy and Toxicity of CD19-Specific Chimeric Antigen Receptor T Cells Alone or in Combination with Ibrutinib for Relapsed and/or Refractory CLL
    Gauthier, Jordan
    Hirayama, Alexandre V.
    Hay, Kevin A.
    Li, Daniel
    Lymp, James
    Sheih, Alyssa
    Purushe, Janaki
    Pender, Barbara S.
    Hawkins, Reed M.
    Vakil, Aesha
    Tinh-Doan Phi
    Steinmetz, Rachel N.
    Chapuis, Aude G.
    Till, Brian G.
    Dhawale, Tejaswini
    Hendrie, Paul C.
    Kiem, Hans-Peter
    Ramos, Jorge
    Shadman, Mazyar
    Cassaday, Ryan D.
    Acharya, Utkarsh H.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [26] Design of a CD19-specific chimeric antigen receptor based on a monoclonal antibody LT19
    Chikaev, Anton
    Belovezhets, Tatyana
    Kulemzin, Sergey
    Filatov, Alexander
    Gorchakov, Andrey
    Taranin, Alexander
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 391 - 391
  • [27] Tumor Targeting Using CD19-Specific CAR (Chimeric Antigen Receptor) for B-Cell Lymphoma
    Tsukahara, Tomonori
    Ohmine, Ken
    Uchibori, Ryosuke
    Ido, Hiroyuki
    Urabe, Masashi
    Mizukami, Hiroaki
    Kume, Akihiro
    Nakamura, Masataka
    Mineno, Junichi
    Takesako, Kazutoh
    Riviere, Isabelle
    Sadelain, Michel
    Brentjens, Renier
    Ozawa, Keiya
    MOLECULAR THERAPY, 2013, 21 : S248 - S249
  • [28] Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells
    Diaconu, Iulia
    Ballard, Brandon
    Zhang, Ming
    Chen, Yuhui
    West, John
    Dotti, Gianpietro
    Savoldols, Barbara
    MOLECULAR THERAPY, 2017, 25 (03) : 580 - 592
  • [29] FIRST CLINICAL TRIALS EMPLOYING SLEEPING BEAUTY SYSTEM AND ARTIFICIAL ANTIGEN PRESENTING CELLS TO GENERATE T CELLS EXPRESSING CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR
    Kebriaei, P.
    Huls, H.
    Singh, H.
    Olivares, S.
    Figliola, M.
    Dawson, M.
    Jena, B.
    Jackson, R.
    Bosque, D.
    Rondon, G.
    McNiece, I.
    Hackett, P.
    Shpall, E.
    Champlin, R.
    Cooper, L.
    HAEMATOLOGICA, 2013, 98 : 489 - 490
  • [30] On the cause and consequence of intestinal domination of Enterococcus spp. in patients treated with CD19-specific chimeric antigen receptor (CAR) T cells
    Rohrbach, R.
    Blumenberg, V.
    Schubert, M. -L.
    Zamir, E.
    Schmidt, S.
    Hillebrandt, N.
    Bozic, D.
    von Bergwelt, M.
    Mueller-Tidow, C.
    Dreger, P.
    Schmitt, M.
    Subklewe, M.
    Stein-Thoeringer, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 192 - 192
12345